-
1
-
-
84863961968
-
U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement
-
V.A. Moyer U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120 134
-
(2012)
Ann Intern Med
, vol.157
, pp. 120-134
-
-
Moyer, V.A.1
-
2
-
-
33750978664
-
PSA screening among elderly men with limited life expectancies
-
L.C. Walter, D. Bertenthal, K. Lindquist, and B.R. Konety PSA screening among elderly men with limited life expectancies JAMA 296 2006 2336 2342
-
(2006)
JAMA
, vol.296
, pp. 2336-2342
-
-
Walter, L.C.1
Bertenthal, D.2
Lindquist, K.3
Konety, B.R.4
-
3
-
-
77949898163
-
Time trends and local variation in primary treatment of localized prostate cancer
-
M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117 1123
-
(2010)
J Clin Oncol
, vol.28
, pp. 1117-1123
-
-
Cooperberg, M.R.1
Broering, J.M.2
Carroll, P.R.3
-
4
-
-
77956811462
-
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
-
A.J. Vickers, A.M. Cronin, and T. Björk Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study BMJ 341 2010 c4521
-
(2010)
BMJ
, vol.341
, pp. 4521
-
-
Vickers, A.J.1
Cronin, A.M.2
Björk, T.3
-
5
-
-
80051646902
-
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators
-
R.K. Nam, M.W. Kattan, and J.L. Chin Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators J Clin Oncol 29 2011 2959 2964
-
(2011)
J Clin Oncol
, vol.29
, pp. 2959-2964
-
-
Nam, R.K.1
Kattan, M.W.2
Chin, J.L.3
-
6
-
-
84868599480
-
Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: Findings from the REDUCE trial
-
A.K. Kader, J. Sun, and B.H. Reck Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial Eur Urol 62 2012 953 961
-
(2012)
Eur Urol
, vol.62
, pp. 953-961
-
-
Kader, A.K.1
Sun, J.2
Reck, B.H.3
-
7
-
-
50949128308
-
Predicting prostate cancer risk through incorporation of prostate cancer gene 3
-
discussion 1308
-
D.P. Ankerst, J. Groskopf, and J.R. Day Predicting prostate cancer risk through incorporation of prostate cancer gene 3 J Urol 180 2008 1303 1308 discussion 1308
-
(2008)
J Urol
, vol.180
, pp. 1303-1308
-
-
Ankerst, D.P.1
Groskopf, J.2
Day, J.R.3
-
8
-
-
33646459214
-
Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial
-
I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 529-534
-
-
Thompson, I.M.1
Ankerst, D.P.2
Chi, C.3
-
9
-
-
69449107322
-
Evidence for field cancerization of the prostate
-
L. Nonn, V. Ananthanarayanan, and P.H. Gann Evidence for field cancerization of the prostate Prostate 69 2009 1470 1479
-
(2009)
Prostate
, vol.69
, pp. 1470-1479
-
-
Nonn, L.1
Ananthanarayanan, V.2
Gann, P.H.3
|